Method for Detecting Thyroid Tumor Based on Imprinted Gene Analysis
AssigneeLisen Imprinting Diagnostics, Inc.
InventorsTong Cheng, Ning Zhou, Xing Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeLisen Imprinting Diagnostics, Inc.
InventorsTong Cheng, Ning Zhou, Xing Li
Estimating the term…
A method for determining a level of malignancy of a thyroid tumor in a subject and treating the subject is provided. A test sample is obtained from the subject, in situ hybridization of probes designed based on the sequence of an intron of imprinted gene HM13 and imprinted gene SNRPN, respectively, with cells of the test sample is performed. The test sample having been subject to the hybridization is stained and the stained cells are observed under a microscope and the microscopic images of the stained test sample are analyzed to calculate parameters relating to the aberrant expression of the at least one imprinted gene. Such aberrant expression is then graded to determine the level of malignancy of a thyroid tumor.
A method for determining a level of malignancy of a thyroid tumor in a subject and treating the subject, comprising:
The method according to any of the foregoing claims, wherein the test sample is human tissue and/or cells.
The method according to any of the foregoing claims, wherein the test sample is a needle biopsy sample.
The method according to any of the foregoing claims, wherein the in situ hybridization is RNAscope in situ hybridization.
Dependencies are inferred from the claim text.